Cargando…
Tocilizumab: Infection and worsening of pre-existing COVID-19 symptoms following off-label treatment: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862866/ http://dx.doi.org/10.1007/s40278-021-90729-9 |
Ejemplares similares
-
Dexamethasone/tocilizumab: Worsening of hepatitis E virus infection following off label use: case report
Publicado: (2022) -
Tocilizumab: Viral myocarditis, increased viral replication and worsening of COVID-19 following off-label use: 2 case reports
Publicado: (2020) -
Tocilizumab: Herpes zoster infection following an off label use: case report
Publicado: (2022) -
Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021) -
Tocilizumab: Neutropenia following off-label use: case report
Publicado: (2021)